Infection and cancer: Global distribution and burden of diseases

Annals of Global Health

Volumn 80, Issue 5, 2014, Pages 384-392

  Oh, Jin Kyoung ^a,b   Weiderpass, Elisabete ^a,c,d,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b National Cancer Center   (South Korea)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d FOLKHÄLSAN RESEARCH CENTER   (Finland)

^e UNIVERSITY OF TROMSØ   (Norway)

Author keywords

burden; cancer; infection; vaccination

Indexed keywords

ADEFOVIR DIPIVOXIL; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; ENTECAVIR; LAMIVUDINE; NUCLEOTIDE; NUCLEOTIDE DERIVATIVE; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN; TELBIVUDINE; TENOFOVIR;

ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ANTIVIRAL THERAPY; BILE DUCT CARCINOMA; BLADDER CANCER; BURKITT LYMPHOMA; CANCER RISK; CARCINOMA; CAUSAL ATTRIBUTION; CLONORCHIASIS; CONDOM USE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS INFECTION; HELICOBACTER INFECTION; HELMINTHIASIS; HEPATITIS B; HEPATITIS C; HERPES VIRUS INFECTION; HODGKIN DISEASE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION; INFECTION PREVENTION; KAPOSI SARCOMA; LEUKEMIA; LIVER CELL CARCINOMA; LYMPHOMA; NASOPHARYNX CARCINOMA; NEOPLASM; NONHODGKIN LYMPHOMA; OPISTHORCHIASIS; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PREVENTIVE HEALTH SERVICE; REVIEW; SAFE SEX; SCHISTOSOMIASIS HAEMATOBIA; SCREENING; STOMACH CARCINOMA; T CELL LEUKEMIA; UTERINE CERVIX CARCINOMA; VACCINATION; EPSTEIN-BARR VIRUS INFECTIONS; HELICOBACTER INFECTIONS; HIV INFECTIONS; HTLV-I INFECTIONS; MICROBIOLOGY; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PARASITOLOGY; TREMATODE INFECTIONS; VIROLOGY; VIRUS DISEASES;

CLONORCHIASIS; EPSTEIN-BARR VIRUS INFECTIONS; HELICOBACTER INFECTIONS; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HTLV-I INFECTIONS; HUMANS; NEOPLASMS; OPISTHORCHIASIS; PAPILLOMAVIRUS INFECTIONS; SCHISTOSOMIASIS HAEMATOBIA; TREMATODE INFECTIONS; VIRUS DISEASES;

EID: 84927634941     PISSN: None     EISSN: 22149996     Source Type: Journal    
DOI: 10.1016/j.aogh.2014.09.013     Document Type: Review

References (92)

1. V. Bouvard, R. Baan, and K. Straif A review of human carcinogens - part B: biological agents Lancet Oncol 10 2009 321 322
2. International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Carcinogen - Part B: Biological Agents 2011 International Agency for Research on Cancer Lyon, France
3. C. de Martel, J. Ferlay, and S. Franceschi Global burden of cancers attributable to infections in 2008: a review and synthetic analysis Lancet Oncol 13 2012 607 615
4. H. Feng, M. Shuda, Y. Chang, and P.S. Moore Clonal integration of a polyomavirus in human Merkel cell carcinoma Science 319 2008 1096 1100
5. M. Shuda, H. Feng, and H.J. Kwun T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus Proc Natl Acad Sci U S A 105 2008 16272 16277
6. GLOBOCAN 2012 [Internet]. International Agency for Research on Cancer. 2013 [cited 07 January 2014]. Available from: http://globocan.iarc.fr/. Accessed October 3, 2014.
7. E.A. Rogena, G. De Falco, K. Schurfeld, and L. Leoncini A review of the trends of lymphomas in the equatorial belt of Africa Hematol Oncol 29 2011 111 115
8. L. Dal Maso, D. Serraino, and S. Franceschi Epidemiology of AIDS-related tumours in developed and developing countries Eur J Cancer 37 2001 1188 1201
9. K. Poomphakwaen, S. Promthet, and S. Kamsa-Ard Risk factors for cholangiocarcinoma in Khon Kaen, Thailand: a nested case-control study Asia Pac J Cancer Prev 10 2009 251 258
10. H.R. Shin, J.K. Oh, and E. Masuyer Comparison of incidence of intrahepatic and extrahepatic cholangiocarcinoma - focus on East and South-Eastern Asia Asia Pac J Cancer Prev 11 2010 1159 1166
11. H. Hjalgrim, J. Friborg, and M. Melbye The epidemiology of EBV and its association with malignant disease A. Arvin, G. Campadelli-Fiume, E. Mocarski, Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis 2007 Cambridge University Press Cambridge, UK
12. N. Raab-Traub Epstein-Barr virus in the pathogenesis of NPC Semin Cancer Biol 12 2002 431 441
13. M. Okano, and T.G. Gross Acute or chronic life-threatening diseases associated with Epstein-Barr virus infection Am J Med Sci 343 2012 483 489
14. J.N. Chen, D. He, F. Tang, and C.K. Shao Epstein-Barr virus-associated gastric carcinoma: a newly defined entity J Clin Gastroenterol 46 2012 262 271
15. C.J. Chen, L.Y. Wang, and M.W. Yu Epidemiology of hepatitis B virus infection in the Asia-Pacific region J Gastroenterol Hepatol 15 Suppl 2000 E3 E6
16. B. Custer, S.D. Sullivan, T.K. Hazlet, U. Iloeje, D.L. Veenstra, and K.V. Kowdley Global epidemiology of hepatitis B virus J Clin Gastroenterol 38 Suppl 3 2004 S158 S168
17. J.J. Ott, G.A. Stevens, J. Groeger, and S.T. Wiersma Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity Vaccine 30 2012 2212 2219
18. L.Y. Cho, J.J. Yang, and K.P. Ko Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis Int J Cancer 128 2011 176 184
19. P. Arbuthnot, and M. Kew Hepatitis B virus and hepatocellular carcinoma Int J Exp Pathol 82 2001 77 100
20. F.V. Chisari Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B Am J Pathol 156 2000 1117 1132
21. C. Brechot, D. Kremsdorf, and P. Soussan Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms Pathologie-biologie 58 2010 278 287
22. M.J. Alter Epidemiology of hepatitis C virus infection World J Gastroenterol 13 2007 2436 2441
23. K. Mohd Hanafiah, J. Groeger, A.D. Flaxman, and S.T. Wiersma Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence Hepatology 57 2013 1333 1342
24. B.D. Lindenbach, B.M. Pragai, and R. Montserret The C terminus of hepatitis C virus NS4A encodes an electrostatic switch that regulates NS5A hyperphosphorylation and viral replication J Virol 81 2007 8905 8918
25. D. Moradpour, F. Penin, and C.M. Rice Replication of hepatitis C virus Nat Rev Microbiol 5 2007 453 463
26. K. Koike Pathogenesis of HCV-associated HCC: dual-pass carcinogenesis through activation of oxidative stress and intracellular signaling Hepatol Res 37 Suppl 2 2007 S115 S1120
27. D.R. McGivern, and S.M. Lemon Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer Annu Rev Pathol 4 2009 399 415
28. M. Dedicoat, R. Newton, and K.R. Alkharsah Mother-to-child transmission of human herpesvirus-8 in South Africa J Infect Dis 190 2004 1068 1075
29. B.I. Malope, R.M. Pfeiffer, and G. Mbisa Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population J Acquir Immune Defic Syndr 44 2007 351 355
30. D. Whitby, M. Luppi, and C. Sabin Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission Br J Cancer 82 2000 702 704
31. S.M. Mbulaiteye, R.M. Pfeiffer, and E.A. Engels Detection of kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda J Infect Dis 190 2004 1382 1386
32. S. Plancoulaine, L. Abel, and M. van Beveren Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population Lancet 356 2000 1062 1065
33. V. Minhas, K.L. Crabtree, and A. Chao Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area Am J Epidemiol 168 2008 311 320
34. A.E. Grulich, P. Cunningham, and M.L. Munier Sexual behaviour and human herpesvirus 8 infection in homosexual men in Australia Sex Health 2 2005 13 18
35. J.N. Martin, D.E. Ganem, D.H. Osmond, K.A. Page-Shafer, D. Macrae, and D.H. Kedes Sexual transmission and the natural history of human herpesvirus 8 infection N Engl J Med 338 1998 948 954
36. N.A. Smith, C.A. Sabin, and R. Gopal Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex J Infect Dis 180 1999 600 606
37. S. Franceschi, M. Lise, and G.M. Clifford Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study Br J Cancer 103 2010 416 422
38. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Intl J Cancer 127 2010 2893 2917
39. A.P. Bhatt, and B. Damania AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV Front Immunol 3 2012 401
40. B. Chandran Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells J Virol 84 2010 2188 2199
41. E.A. Mesri, E. Cesarman, and C. Boshoff Kaposi's sarcoma and its associated herpesvirus Nat Rev Cancer 10 2010 707 719
42. B. Damania, and E. Cesarman Kaposi's sarcoma-associated herpesvirus D.M. Knipe, P. Howley, Fields Virology 6th ed. 2013 Lippincott Williams & Wilkins Philadelphia 2080 2128
43. J.S. Lee, Q. Li, and J.Y. Lee FLIP-mediated autophagy regulation in cell death control Nat Cell Biol 11 2009 1355 1362
44. X. Lei, Z. Bai, and F. Ye Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA Nat Cell Biol 12 2010 193 199
45. A.M. Leidal, D.P. Cyr, R.J. Hill, P.W. Lee, and C. McCormick Subversion of autophagy by Kaposi's sarcoma-associated herpesvirus impairs oncogene-induced senescence Cell Host Microbe 11 2012 167 180
46. A.P. Bhatt, S.R. Jacobs, and A.J. Freemerman Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma Proc Natl Acad Sci U S A 109) 2012 11818 11823
47. T. Delgado, P.A. Carroll, A.S. Punjabi, D. Margineantu, D.M. Hockenbery, and M. Lagunoff Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells Proc Natl Acad Sci U S A 107 2010 10696 10701
48. T. Delgado, E.L. Sanchez, R. Camarda, and M. Lagunoff Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection PLoS Pathog 8 2012 e1002866
49. The Joint United Nations Programme on HIV/AIDS (UNAIDS) Global Report: UNAIDS Report on the Global AIDS Epidemic 2013 2013 UNAIDS Geneva, Switzerland
50. J.M. Walboomers, M.V. Jacobs, and M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
51. S. de Sanjose, W.G. Quint, and L. Alemany Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Lancet Oncol 11 2010 1048 1056
52. N. Li, S. Franceschi, R. Howell-Jones, P.J. Snijders, and G.M. Clifford Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication Intl J Cancer 128 2011 927 935
53. E.M. de Villiers, C. Fauquet, T.R. Broker, H.U. Bernard, and H. zur Hausen Classification of papillomaviruses Virology 324 2004 17 27
54. A.N. Burchell, R.L. Winer, S. de Sanjose, and E.L. Franco Epidemiology and transmission dynamics of genital HPV infection Vaccine 24 Suppl 3 2006 S3/52 61
55. L. Bruni, M. Diaz, X. Castellsague, E. Ferrer, F.X. Bosch, and S. de Sanjose Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings J Infect Dis 202 2010 1789 1799
56. R. Ghittoni, R. Accardi, U. Hasan, T. Gheit, B. Sylla, and M. Tommasino The biological properties of E6 and E7 oncoproteins from human papillomaviruses Virus Genes 40 2010 1 13
57. S.N. Boyer, D.E. Wazer, and V. Band E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway Cancer Res 56 1996 4620 5624
58. K. Munger, J.R. Basile, and S. Duensing Biological activities and molecular targets of the human papillomavirus E7 oncoprotein Oncogene 20 2001 7888 7898
59. M. Tommasino, R. Accardi, and S. Caldeira The role of TP53 in cervical carcinogenesis Hum Mutat 21 2003 307 312
60. A. Manns, M. Hisada, and L. La Grenade Human T-lymphotropic virus type I infection Lancet 353 1999 1951 1958
61. F.A. Proietti, A.B. Carneiro-Proietti, B.C. Catalan-Soares, and E.L. Murphy Global epidemiology of HTLV-I infection and associated diseases Oncogene 24 2005 6058 6068
62. E.L. Murphy, B. Hanchard, and J.P. Figueroa Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I Intl J Cancer 43 1989 250 253
63. R. Pawson, T. Schulz, E. Matutes, and D. Catovsky Absence of HTLV-I/II in T-prolymphocytic leukaemia Br J Haematol 102 1998 872 873
64. M. Matsuoka, and K.T. Jeang Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation Nat Rev Cancer 7 2007 270 280
65. L.M. Brown Helicobacter pylori: epidemiology and routes of transmission Epidemiol Rev 22 2000 283 297
66. P. Correa, and J. Houghton Carcinogenesis of Helicobacter pylori Gastroenterology 133 2007 659 672
67. L.E. Wroblewski, and R.M. Peek Jr. Helicobacter pylori in gastric carcinogenesis: mechanisms Gastroenterol Clin North Am 42 2013 285 298
68. P. Jongsuksuntigul, and T. Imsomboon Opisthorchiasis control in Thailand Acta Trop 88 2003 229 232
69. B. Fried, A. Reddy, and D. Mayer Helminths in human carcinogenesis Cancer Lett 305 2011 239 249
70. A. Shin, S. Park, and H.R. Shin Population attributable fraction of infection-related cancers in Korea Ann Oncol 22 2011 1435 1442
71. H.R. Shin, J.K. Oh, and M.K. Lim Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea J Korean Med Sci 25 2010 1011 1016
72. M.H. Choi, I.C. Park, S. Li, and S.T. Hong Excretory-secretory antigen is better than crude antigen for the serodiagnosis of clonorchiasis by ELISA Korea J Parasitol 41 2003 35 39
73. B. Sripa, and S. Kaewkes Localisation of parasite antigens and inflammatory responses in experimental opisthorchiasis Intl J Parasitol 30 2000 735 740
74. S. Wongratanacheewin, D. Bunnag, N. Vaeusorn, and S. Sirisinha Characterization of humoral immune response in the serum and bile of patients with opisthorchiasis and its application in immunodiagnosis Am J Trop Med Hyg 38 2 1988 356 362
75. B. Sripa Pathobiology of opisthorchiasis: an update Acta Trop 88 2003 209 220
76. M.P. Rosin Saad el Din Zaki S, Ward AJ, Anwar WA. Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients Mutat Res 305 1994 283 292
77. A.F. Badawi Molecular and genetic events in schistosomiasis-associated human bladder cancer: role of oncogenes and tumor suppressor genes Cancer Lett 105 1996 123 138
78. M.P. Rosin, W.A. Anwar, and A.J. Ward Inflammation, chromosomal instability, and cancer: the schistosomiasis model Cancer Res 54 Suppl 1994 1929s 1933s
79. P. Pisani, D.M. Parkin, N. Munoz, and J. Ferlay Cancer and infection: estimates of the attributable fraction in 1990 Cancer Epidemiol Biomarkers Prev 6 1997 387 400
80. D.M. Parkin The global health burden of infection-associated cancers in the year 2002 Intl J Cancer 118 2006 3030 3044
81. Y.F. Liaw, and C.M. Chu Hepatitis B virus infection Lancet 373 2009 582 592
82. J.M. Pawlotsky Treatment of chronic hepatitis C: current and future Curr Top Microbiol Immunol 369 2013 321 342
83. K.M. Fock, P. Katelaris, and K. Sugano Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection J Gastroenterol Hepatol 24 2009 1587 1600
84. R.H. Hunt, S.D. Xiao, and F. Megraud Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline J Gastrointestin Liver Dis 20 2011 299 304
85. P. Malfertheiner, F. Megraud, and C.A. O'Morain Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report Gut 61 2012 646 664
86. W.D. Chey, and B.C. Wong Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection Am J Gastroenterol 102 2007 1025 1808
87. K. Fukase, M. Kato, and S. Kikuchi Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial Lancet 372 2008 392 397
88. J.L. Ma, L. Zhang, and L.M. Brown Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality J Natl Cancer Inst 104 2012 488 492
89. J.Y. Park, D. Forman, E.R. Greenberg, and R. Herrero Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed? Curr Oncol Rep 15 2013 517 525
90. J. Keiser, and M. Vargas Effect of artemether, artesunate, OZ78, praziquantel, and tribendimidine alone or in combination chemotherapy on the tegument of Clonorchis sinensis Parasitol Intl 59 2010 472 476
91. P. Soukhathammavong, P. Odermatt, and S. Sayasone Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial Lancet Infect Dis 11 2011 110 118
92. S.H. Xiao, J. Xue, L.L. Xu, Y.N. Zhang, and H.Q. Qiang Comparative effect of mebendazole, albendazole, tribendimidine, and praziquantel in treatment of rats infected with Clonorchis sinensis Parasitol Res 108 2011 723 730